This is the authors' abstract. We don't add key points for this paper.
The carbon footprint of devices to deliver inhaled respiratory medications has come into focus as climate change has been identified as a worldwide emergency. Metered dose inhalers (MDIs) contain hydrofluorocarbons that have significant global warming potential compared to dry powder inhalers (DPIs) and soft mist inhalers (SMIs), which do not use a propellant gas. A 12-month pharmacy inpatient dispensing audit demonstrated that inpatient MDI use significantly outweighed that of DPIs and SMIs and accounted for approximately 99% of inhaler-related greenhouse gas emissions at our hospital.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Cushnahan et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: